Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer
出版年份 2021 全文链接
标题
Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer
作者
关键词
Polymersome, Doxorubicin, Camptothecin, Hyaluronic acid, Non-small cell lung cancer, FOXM1
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 335, Issue -, Pages 369-388
出版商
Elsevier BV
发表日期
2021-05-28
DOI
10.1016/j.jconrel.2021.05.039
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment
- (2020) Nusrat Chowdhury et al. AAPS PHARMSCITECH
- Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo
- (2020) Negin Ghandhariyoun et al. LIFE SCIENCES
- Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44
- (2019) Alice Spadea et al. MOLECULAR PHARMACEUTICS
- Co-delivery of Doxorubicin and Afatinib with pH-responsive Polymeric Nanovesicle for Enhanced Lung Cancer Therapy
- (2019) Heng-Ye Gong et al. CHINESE JOURNAL OF POLYMER SCIENCE
- Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer
- (2019) Mahsa Shahriari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fabrication of hybrid scaffold based on hydroxyapatite-biodegradable nanofibers incorporated with liposomal formulation of BMP-2 peptide for bone tissue engineering
- (2018) Marzieh Mohammadi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Aptamer Therapeutics in Cancer: Current and Future
- (2018) Yoshihiro Morita et al. Cancers
- Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers
- (2018) Khalil Abnous et al. Expert Opinion on Drug Delivery
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers
- (2018) Poonam Parashar et al. Drug Delivery and Translational Research
- Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
- (2018) Chunyan Gu et al. BMC CANCER
- Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy
- (2018) Yu Xia et al. International Journal of Nanomedicine
- Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improve long circulation and enhance cellular uptake in cancer therapy
- (2018) Lu Zhong et al. Acta Pharmaceutica Sinica B
- Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
- (2017) Shun-ichi Watanabe et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation
- (2017) Mona Alibolandi et al. JOURNAL OF CONTROLLED RELEASE
- Effect of irinotecan on HMGB1, MMP9 expression, cell cycle, and cell growth in breast cancer (MCF-7) cells
- (2017) Saeedeh Keyvani-Ghamsari et al. TUMOR BIOLOGY
- Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
- (2017) Miso Kim et al. Cancer Research and Treatment
- pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin
- (2017) Shengcai Yang et al. Biomaterials Science
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
- (2017) Alexander Y. Deneka et al. PLoS One
- Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX
- (2017) Qin Xiang et al. Scientific Reports
- A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling
- (2016) Han-Lin Chou et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
- (2016) Takeshi Kawakami et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy
- (2016) Bo Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Dextran-poly lactide- co -glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo
- (2016) Mona Alibolandi et al. JOURNAL OF CONTROLLED RELEASE
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- Anticancer Effects of Sinulariolide-Conjugated Hyaluronan Nanoparticles on Lung Adenocarcinoma Cells
- (2016) Kuan Hsiao et al. MOLECULES
- Enzyme Degradable Polymersomes from Hyaluronic Acid-block-poly(ε-caprolactone) Copolymers for the Detection of Enzymes of Pathogenic Bacteria
- (2015) Simon Haas et al. BIOMACROMOLECULES
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model
- (2015) Mona Alibolandi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid
- (2015) Kathryn M. Camacho et al. JOURNAL OF CONTROLLED RELEASE
- In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer
- (2015) Mona Alibolandi et al. JOURNAL OF CONTROLLED RELEASE
- Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
- (2015) George Mattheolabakis et al. JOURNAL OF DRUG TARGETING
- Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs
- (2015) Mona Alibolandi et al. JOURNAL OF NANOPARTICLE RESEARCH
- CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling
- (2015) Jie Su et al. MOLECULAR CARCINOGENESIS
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Treatment of Stage I and II Non-small Cell Lung Cancer
- (2013) John A. Howington et al. CHEST
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer
- (2012) Insoo Kim et al. BIOMATERIALS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
- (2012) Yu Wang et al. LUNG CANCER
- Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
- (2012) Marianna Halasi et al. PLoS One
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started